Canopy Growth Corp - Asset Resilience Ratio
Canopy Growth Corp (WEED) has an Asset Resilience Ratio of 0.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Canopy Growth Corp's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2026)
This chart shows how Canopy Growth Corp's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Canopy Growth Corp.
Liquid Assets Composition Over Time
This chart breaks down Canopy Growth Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Canopy Growth Corp (WEED) long-term investment share to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$5.05 Million | 0.45% |
| Total Liquid Assets | CA$5.05 Million | 0.45% |
Asset Resilience Insights
- Limited Liquidity: Canopy Growth Corp maintains only 0.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Canopy Growth Corp Industry Peers by Asset Resilience Ratio
Compare Canopy Growth Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for Canopy Growth Corp (2015–2026)
The table below shows the annual Asset Resilience Ratio data for Canopy Growth Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 0.45% | CA$5.05 Million ≈ $3.65 Million |
CA$1.12 Billion ≈ $809.27 Million |
-1.49pp |
| 2025-03-31 | 1.94% | CA$17.79 Million ≈ $12.87 Million |
CA$917.70 Million ≈ $663.85 Million |
-5.39pp |
| 2024-03-31 | 7.33% | CA$95.34 Million ≈ $68.97 Million |
CA$1.30 Billion ≈ $940.64 Million |
-5.79pp |
| 2023-03-31 | 13.13% | CA$320.14 Million ≈ $231.59 Million |
CA$2.44 Billion ≈ $1.76 Billion |
-2.92pp |
| 2022-03-31 | 16.05% | CA$900.97 Million ≈ $651.75 Million |
CA$5.62 Billion ≈ $4.06 Billion |
-11.25pp |
| 2021-03-31 | 27.30% | CA$1.86 Billion ≈ $1.35 Billion |
CA$6.82 Billion ≈ $4.94 Billion |
+8.39pp |
| 2020-03-31 | 18.91% | CA$1.30 Billion ≈ $938.17 Million |
CA$6.86 Billion ≈ $4.96 Billion |
-13.62pp |
| 2019-03-31 | 32.53% | CA$2.84 Billion ≈ $2.05 Billion |
CA$8.73 Billion ≈ $6.32 Billion |
+32.48pp |
| 2018-03-31 | 0.05% | CA$664.00K ≈ $480.33K |
CA$1.44 Billion ≈ $1.04 Billion |
-12.51pp |
| 2017-03-31 | 12.56% | CA$85.10 Million ≈ $61.56 Million |
CA$677.61 Million ≈ $490.17 Million |
+12.52pp |
| 2015-03-31 | 0.04% | CA$10.00K ≈ $7.23K |
CA$25.96 Million ≈ $18.78 Million |
-- |
About Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and … Read more